COMMUNIQUÉS West-GlobeNewswire

-
MPI - FDA approves OVs IDE and IND for ovarian cancer with its PARP inhibitor and DRP
27/08/2018 -
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
27/08/2018 -
Misonix to Report Fiscal 2018 Fourth Quarter Financial Results and Host Conference Call and Webcast on September 5
27/08/2018 -
Biohit Oyj: Managers' Transactions
27/08/2018 -
Biohit Oyj: Managers' Transactions
27/08/2018 -
Sienna Biopharmaceuticals Announces Results from First-in-Human Study of SNA-125 in Psoriasis and Continued Progression to Phase 2
27/08/2018 -
Obalon Therapeutics Announces Closing of $10 Million Private Placement
27/08/2018 -
Delcath Announces Acceptance of Abstract for Poster Presentation at CIRSE 2018
27/08/2018 -
Naturally Splendid Increases Vertical Integration and Expands International Footprint -- CFN Media
27/08/2018 -
Lexington Announces Non-Brokered Private Placement
27/08/2018 -
AXIM® Biotechnologies Enters Canadian Market Through New Exclusive Distribution and License Agreement With Revive Therapeutics
27/08/2018 -
Scythian Biosciences Closes Acquisition of MMJ Colombia Partners
27/08/2018 -
Solon Eiendom ASA – Primary insider notification
27/08/2018 -
Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development
27/08/2018 -
Novo Nordisk A/S - Share repurchase programme
27/08/2018 -
NRC Health Releases First Loyalty-Based U.S. Hospital Rankings
27/08/2018 -
BioCanCell Announces Company Name Change to Anchiano Therapeutics
27/08/2018 -
Assure Holdings to Present at the 7th Annual Liolios Gateway Conference on September 5, 2018
27/08/2018 -
Rhinogram Announces Appointment of New President to Guide Expansion into Medical Practice Market
27/08/2018
Pages